country

Change Language

EN - English
FR - Français
DE - Deutsch
ES - Español
JA - 日本語
KO - 한국어

Country or Region:

United States

Product Name	Size / Unit Price	Qty

Total: USD 0.00 Checkout

Cat. No.: HY-W305227

Copy Link Print Information

INN-312

INN-312 is a sickle hemoglobin (Hb S) inhibitor capable of penetrating red blood cell membranes. INN-312 inhibits sickling of sickle red blood cells under hypoxic conditions, increases the oxygen affinity of Hb, and moderately improves the solubility of deoxygenated Hb S. INN-312 can be used in research related to sickle cell disease.

연구목적의 판매만을 진행합니다. 환자를 대상으로 한 판매는 하지 않습니다.

CAS No.: 923255-75-8
화학식: C₁₄H₁₃NO₃
분자량:243.26

보관:

Please store the product under the recommended conditions in the Certificate of Analysis.

INN-312 Chemical Structure

CAS No.: 923255-75-8

사이즈

가격

재고

수량

Amount: USD 0.00

* 장바구니에 담기 전 물품의 수량을 선택해 주십시오.

Top Publications Citing

Use of MCE Products

Fluorescent Dye

Strong Fluorescence Signal / Multi-Disciplinary Applications / High Fluorescence Specificity

Biological Activity
- 제품 설명
- In Vitro
- In Vivo
Chemical Information
순도&문서
References
Calculators
Help & FAQs
Classifications
Bioz

Biological Activity

제품 설명

In Vitro

INN-312 (0.5-2 mM) dose-dependently inhibits sickling of sickle erythrocytes (SS cells) under hypoxic conditions at 37°C, with 81% inhibition at 2 mM^[1].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

In Vivo

INN-312 (50-150 mg/kg; i.p.; single dose) produces dose-dependent increases in AUC_0-t and C_max in transgenic sickle mice, with consistent pharmacokinetic parameters across doses, and strongly shifts hemoglobin OEC leftward^[1].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

Animal Model:

Transgenic sickle mice^[1]
Dosage:

50 mg/kg; 100 mg/kg; 150 mg/kg
Administration:

i.p.; single dose
Result:

Produced AUC values of 314 µg/mL/min, 648 µg/mL/min, and 1044 µg/mL/min for 50, 100, and 150 mg/kg doses, respectively.
Showed terminal half-life of 0.75 h, peak concentration time of 0.5 h, and mean resident time of 1.2 h, consistent across all dosage groups.
Increased maximum plasma concentration in a dose-dependent manner.
Shifted hemoglobin oxygen equilibrium curve toward the left more strongly than various previously reported compounds.

Chemical Information

CAS No. 923255-75-8
분자량 243.26
화학식 C₁₄H₁₃NO₃
SMILES

O=CC1=CC(OC)=CC=C1OCC=2C=NC=CC2
선적

Room temperature in continental US; may vary elsewhere.
보관

Please store the product under the recommended conditions in the Certificate of Analysis.

순도&문서

Handling Instructions (2659 KB)

References

[1]. Abdulmalik, O. Y., et al. (2005). In Vitro Antisickling Effects of Novel Pyridyl Derivatives with Enhanced Potency. Blood, 106(11), 2347.

[2]. Abdulmalik O, et al. VZHE-039, a novel antisickling agent that prevents erythrocyte sickling under both hypoxic and anoxic conditions. Scientific reports. 2020 Nov 20;10(1):20277. [Content Brief]

Calculators

몰농도 계산기

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

Mass Mass

Concentration Concentration

Volume Volume

Molecular Weight Molecular Weight

농도 희석 계산기

Concentration _(start) × Volume _(start) = Concentration _(final) × Volume _(final)

Concentration _(start) Concentration _(start)

Volume _(start) Volume _(start)

Concentration _(final) Concentration _(final)

Volume _(final) Volume _(final)

Help & FAQs

How should lyophilized recombinant proteins be reconstituted and stored?

1. Before opening the cap, centrifuge the vial at 13000 rpm for 20-30 seconds. This step will ensure that any lyophilized powder that may have adhered to the cap or walls is collected at the bottom of the vial, minimizing the risk of product loss.

Keywords

MOQ

Minimum order quantity

100 mg

견적 받기 해외재고보유

Other size

견적 받기